Download the Executive Brief (PDF)
👉 Download the Executive Brief
Thank you for downloading the Executive Brief.
A concise executive perspective on how 12–24 month runway assumptions become quietly distorted across R&D, CMC, regulatory, and commercial interfaces — long before the impact appears in burn rate, valuation, or deal terms.
Designed for biotech and medtech SME leaders who want earlier structural visibility into capital exposure and financing risk.
If, after reading, you would like to translate this perspective into indicative runway risk and cost exposure for your organisation, the Runway Risk & Cost Exposure Audit™ is available as a standalone diagnostic.